Hypoglycaemia News and Research

RSS
New positive data on Generex Oral-lyn published in Diabetes, Obesity and Metabolism

New positive data on Generex Oral-lyn published in Diabetes, Obesity and Metabolism

Linagliptin clinical trial data shows positive result for type 2 diabetes treatment

Linagliptin clinical trial data shows positive result for type 2 diabetes treatment

Linagliptin mono- and combination therapy improves blood glucose control

Linagliptin mono- and combination therapy improves blood glucose control

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Roche implements risk mitigation plan in taspoglutide Phase III programme

Roche implements risk mitigation plan in taspoglutide Phase III programme

Additional benefits of LAIAs over long-acting human insulin not been proven

Additional benefits of LAIAs over long-acting human insulin not been proven

LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

LCT receives grant of $500,000 for Phase II clinical trial of DIABECELL in New Zealand

LCT receives approval for New Zealand Phase II human trial of DIABECELL

LCT receives approval for New Zealand Phase II human trial of DIABECELL

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Non-insulin-dependent patients with type 2 diabetes do not benefit from glucose self-monitoring

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Children with type 1 diabetes benefit from rapid-acting insulin analogues; potential harm remains unclear

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

Liraglutide drug causes less nausea and hypoglycaemia compared to exenatide

Important guidelines from IDF for diabetes care

Important guidelines from IDF for diabetes care

Merck Frosst Canada's JANUMET receives Notice of Compliance in Canada

Merck Frosst Canada's JANUMET receives Notice of Compliance in Canada

Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

Sanofi-aventis announces study results comparing efficacy of Lantus to detemir

Research looks at enzyme that causes genetic diseases

Research looks at enzyme that causes genetic diseases

Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven

Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven

Biphasic insulin provides significant improvements in more than 52,000 diabetic patients

Biphasic insulin provides significant improvements in more than 52,000 diabetic patients

Fear of hypoglycemia a barrier to exercise for type 1 diabetics

Fear of hypoglycemia a barrier to exercise for type 1 diabetics

Managing diabetes at school

Managing diabetes at school

Charity says rules for diabetic drivers unfair

Charity says rules for diabetic drivers unfair